Nashville — Nashville, Tennessee

Nashville is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Nashville has participated in 15 clinical trials with 2 currently active.

Therapeutic areas: Seizures, Prostate Cancer, Neovascular Age-Related Macular Degeneration (NVAMD).

Sponsors: AbbVie, Myovant Sciences GmbH, EyeBiotech Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville?

Nashville has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville conducted?

Nashville has 15 clinical trials on record, with 2 currently active. Their work covers Seizures, Prostate Cancer, Neovascular Age-Related Macular Degeneration (NVAMD).

Is Nashville accredited by Crixeo Clinical Trials?

Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.